Species/Model | Tissue | Method | Level | References |
---|---|---|---|---|
1,N2-εdGuo | ||||
Human cell line IMR-90 | Lung | LC-ESI-MS/MS | 0.2–1.8/107 dGuo | [118] |
Human cell line SW480 | Colon adenocarcinoma | LC-ESI-MS/MS | 0.5–2/107 dGuo | [119] |
Human cell line A549 | Lung | LC-ESI-MS/MS | 1.5–5/106 dGuo | [45] |
Rat | Liver | LC-ESI-MS/MS | 1–3.25/106 dGuo | [44] |
Rat | Lung | LC-ESI-MS/MS | 1.5–2.5/106 dGuo | [44] |
1,N6-εdAdo | ||||
Human | Lung | 32P-postlabeling | 2.4–146/109 dAdo | [139] |
Human cell line A549 | Lung | LC-ESI-MS/MS | 0.1–0.45/106 dGuo | [45] |
Human | White Blood Cells | 32P-postlabeling | 0.08–24.07/108 dAdo | [140] |
Human | White Blood Cells | 32P-postlabeling | 138–1017/109 dAdo | [141] |
Human | White Blood Cells | 32P-postlabeling | 0.03–90.15/107 dAdo | [142] |
Rat | Liver | LC-ESI-MS/MS | 0.75–2/106 dGuo | [44] |
Rat | Liver | LC-ESI-MS/MS | 2.1–6.9/108 tdn | [143] |
Rat | Lung | LC-ESI-MS/MS | 0.5–1.25/106 dGuo | [44] |